The Selling of ADHD: Diagnoses, Prescriptions Soar After 20-Year Effort by Big Pharma
Taken at face value, the latest figures on Attention Deficit Hyperactivity Disorder (ADHD) suggest a growing epidemic in the United States. According to the Centers for Disease Control, 15 percent of high school children are diagnosed with ADHD. The number of those on stimulant medication is at 3.5 million, up from 600,000 two decades ago. ADHD is now the second most common long-term diagnosis in children, narrowly trailing asthma. But a new report in the New York Times questions whether these staggering figures reflect a medical reality, or an over-medicated craze that has earned billions in profits for the pharmaceutical companies involved.
- See more at: http://tv.greenmedinfo.com/selling-adhd-diagnoses-prescriptions-soar-20-year-effort-big-pharma/#sthash.l4jgR4Ur.OZPsjc7t.dpuf
Taken at face value, the latest figures on Attention Deficit
Hyperactivity Disorder (ADHD) suggest a growing epidemic in the United
States. According to the Centers for Disease Control, 15 percent of high
school children are diagnosed with ADHD. The number of those on
stimulant medication is at 3.5 million, up from 600,000 two decades ago.
ADHD is now the second most common long-term diagnosis in children,
narrowly trailing asthma. But a new report in the New York Times
questions whether these staggering figures reflect a medical reality, or
an over-medicated craze that has earned billions in profits for the
pharmaceutical companies involved.
No comments:
Post a Comment